Stepwise phage resistance and collateral phage susceptibility in Klebsiella pneumoniae

Xin Yin1,2,3, Yu Feng1,2,3, Huan Luo4

  • 1Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Insights

A novel phage cocktail effectively restrains carbapenem-resistant Klebsiella pneumoniae (CRKP) growth. This strategy leverages phages targeting diverse bacterial receptors, offering a promising approach for combating difficult-to-treat infections.

Area of Science:

  • Microbiology and Virology
  • Bacteriophage Therapy
  • Antimicrobial Resistance

Background:

  • Carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a significant global health threat due to limited treatment options.
  • Bacteriophage therapy presents a potential alternative or adjunct to antibiotics for combating resistant bacterial infections.
  • Understanding phage-bacterial interactions is crucial for developing effective phage cocktails.

Purpose of the Study:

  • To develop a phage cocktail capable of prolonging the inhibition of CRKP regrowth.
  • To elucidate the specific bacterial receptors targeted by individual phages within the cocktail.
  • To investigate the mechanisms of phage resistance and cross-genus activity.

Main Methods:

  • Stepwise isolation of lytic phages (P04, P40, P49) against ST11-KL64 CRKP.
  • Construction and evaluation of a three-phage cocktail for CRKP growth inhibition.
  • Analysis of phage-resistant mutants, including genomic analysis (insertion sequences, gene deletions), lipid metabolism assays, and receptor identification (CPS, LPS, transmembrane proteins, BtuB).

Main Results:

  • The developed phage cocktail (P04, P40, P49) restrained CRKP growth for 15 hours.
  • Phage P04 targets capsular polysaccharide (CPS); P04/P40 resistance involved homologous recombination and deletion of ugd/wbgU genes, altering lipid A modification and outer membrane.
  • Phage P40 targets an unidentified membrane protein or lipid A; Phage P49 targets a vitamin B12 transporter (BtuB), exhibiting cross-genus activity against Salmonella, E. coli, E. ludwigii, and K. tianfuensis.

Conclusions:

  • The synergistic activity of phages targeting distinct receptors (CPS, outer membrane components, BtuB) is key to cocktail efficacy.
  • The 'close-one-door-but-open-another' phenomenon, where inhibiting CPS synthesis exposes new receptors, enhances phage effectiveness.
  • Insertion sequences act as a generalized anti-phage defense, and BtuB's conserved structure explains P49's cross-genus activity, offering insights for novel phage cocktail development.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
37
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
69.3K
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
2.2K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.3K